TMO vs TRNS · P/E 24, rev $23.00B vs P/E 57, rev $92.9M
Thermo Fisher Scientific Inc (TMO) versus Transcat Inc (TRNS) — a side-by-side from cached financials, not a winner call.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Transcat Inc (TRNS) is a specialty business services company listed on US.
Latest reported TMO revenue for 2026-06-27 was $23.00B. Net income was $3.39B. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Latest reported TRNS revenue for 2026-06-27 was $92.9M. Net income was $1.3M. Revenue was down 61.7% from 2025-12-27 to 2026-06-27. TRNS currently screens at market cap $837.5M and trailing P/E 57.2.
TMO currently screens at market cap $153.06B and trailing P/E 23.8. TRNS currently screens at market cap $837.5M and trailing P/E 57.2.
Not investment advice. Open the TMO and TRNS stock pages for the full models.
Not investment advice.